Helical

Virtual AI platform for drug discovery

Seed
London, UK
Founded 2026
Website

About

Helical is a London-based biotech startup founded by three Luxembourgish childhood friends. It has developed a virtual AI lab platform that integrates biological foundation models to scale and automate drug discovery workflows at pharmaceutical scale. The platform focuses on reproducible in-silico discovery processes, accelerating pharma R&D by turning bio foundation models into practical systems. Helical raised a $10 million seed round led by Redalpine and supported by Gradient, BoxGroup, and Frst investors to expand its product and market reach.

Products

  • Virtual AI Lab — A platform that integrates biological foundation models to enable reproducible, scalable AI-driven drug discovery workflows.
    Customer sectors: pharmaceuticals, biotech

Company Details

Sector Deep Tech
Category Biotech & Therapeutics
Stage Seed
Total Funding $10.0M
Employees 11-50
Last Funded April 14, 2026
Last Round $10.0M

Market research & competitive positioning

Source-backed TAM / SAM / SOM sizing, displacement analysis, and an interactive peer positioning map for Helical — available to members.

Create a free account Sign in